Sign In
Buy HSDT
$1.51
-0.120 (-7.36%)
At Close: Jun 23, 2026
Helius Medical Technologies, Inc. Announces Launch of Patient Therapy Access Program for PoNS®
11:05am, Wednesday, 01'st Jun 2022 GlobeNewswire Inc.
New program seeks to expand access to patients suffering from multiple sclerosis (MS) New program seeks to expand access to patients suffering from multiple sclerosis (MS)
Helius Medical Announces Poster to Be Presented at the Consortium for Multiple Sclerosis Centers (CMSC) Annual Conference
12:36pm, Tuesday, 31'st May 2022 GlobeNewswire Inc.
NEWTOWN, Pa., May 31, 2022 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq: HSDT) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today annou
Helius Medical Technologies, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
08:05pm, Tuesday, 24'th May 2022 GlobeNewswire Inc.
NEWTOWN, Pa., May 24, 2022 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq: HSDT) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today annou
Helius Medical Technologies, Inc. Announces Participation of Dr. Deborah Backus and Shepherd Center in its Therapeutic Experience Program
11:30am, Tuesday, 17'th May 2022 GlobeNewswire Inc.
-- Second Center of Excellence added in multi-center, company-sponsored, open label observational interventional trial to evaluate the impact of subjects’ adherence to PoNS® therapy for gait improv
Helius Medical Technologies' (HSDT) CEO Dane Andreeff on Q1 2022 Results - Earnings Call Transcript
12:08pm, Thursday, 12'th May 2022
Helius Medical Technologies, Inc. (NASDAQ:HSDT ) Q1 2022 Earnings Conference Call May 12, 2022 9:00 AM ET Company Participants Judy DiClemente – In-Site Communications, Inc. Dane Andreeff – Presid
Helius Medical Technologies, Inc. Reports First Quarter 2022 Financial Results and Provides Update on U.S. Commercial Launch of PoNS®
10:50am, Thursday, 12'th May 2022 GlobeNewswire Inc.
-- Company to host call at 9:00am today with CEO, CFO, CMO and VP Sales & Marketing -- NEWTOWN, Pa., May 12, 2022 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or
Helius Medical Technologies, Inc. to Release First Quarter 2022 Financial Results on May 12, 2022
11:05am, Tuesday, 03'rd May 2022 GlobeNewswire Inc.
NEWTOWN, Pa., May 03, 2022 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ: HSDT) (TSX: HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness,
Helius Medical Technologies, Inc. to Release First Quarter 2022 Financial Results on May 12, 2022
07:05am, Tuesday, 03'rd May 2022
NEWTOWN, Pa., May 03, 2022 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ: HSDT) (TSX: HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, to
Helius Medical Technologies, Inc. Fulfills First U.S. Prescriptions for PoNS®
11:05am, Wednesday, 27'th Apr 2022 GlobeNewswire Inc.
-- First patients have purchased PoNS devices to initiate PoNS Therapy ---- Nineteen PoNS device prescriptions have been written in the U.S. since recent commercial launch -- NEWTOWN, Pa., April 27,
Helius Medical Technologies, Inc. Introduces Device in U.S. To Help Multiple Sclerosis Patients Improve Walking Ability
11:05am, Tuesday, 26'th Apr 2022 GlobeNewswire Inc.
-- Breakthrough technology for MS patients helps patients with gait deficit
Helius Medical Technologies, Inc. (HSDT) CEO Dane Andreeff on Q4 2021 Results - Earnings Call Transcript
09:39pm, Monday, 14'th Mar 2022
Helius Medical Technologies, Inc. (HSDT) CEO Dane Andreeff on Q4 2021 Results - Earnings Call Transcript
Helius Medical Technologies GAAP EPS of -$1.31 misses by $0.15, revenue of $0.26M beats by $0.16M
08:09pm, Monday, 14'th Mar 2022 Seeking Alpha
Helius Medical Technologies press release (NASDAQ:HSDT): Q4 GAAP EPS of -$1.31 misses by $0.15.Revenue of $0.26M (+36.8% Y/Y) beats by $0.16M.
Helius Medical Technologies, Inc. Reports Fourth Quarter and Full Year 2021 Financial Results
08:05pm, Monday, 14'th Mar 2022 GlobeNewswire Inc.
NEWTOWN, Pa., March 14, 2022 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today repo
Helius Medical Technologies, Inc. Reports Fourth Quarter and Full Year 2021 Financial Results
08:05pm, Monday, 14'th Mar 2022 GlobeNewswire
NEWTOWN, Pa., March 14, 2022 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today reported financial results for the quarter and full year ended December 31, 2021.
Helius Medical Technologies, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
10:20pm, Thursday, 17'th Feb 2022 GlobeNewswire Inc.
NEWTOWN, Pa., Feb. 17, 2022 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq: HSDT) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today anno
